CClinicalTrials.gg
Status unknownNCT05214235Updated Jun 16, 2022

A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients

An observational study in Diabetes Mellitus and Spinal Diseases, sponsored by Xijing Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-06-16.

Sponsored by Xijing Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
124
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Diabetes mellitus is a group of metabolic diseases caused by multiple etiologies and characterized by chronic hyperglycemia. It seriously harms human health and has become a global public health challenge. Diabetes mellitus is present in 5% to 25% of patients undergoing spine surgery, and the prevalence has been increasing over the past decade. It is worth noting that spinal surgery for patients with diabetes has significant risks, mainly manifested in the significant increase of postoperative complications such as wound infection, delayed healing and wound hematoma, which seriously affect the long-term prognosis of patients' quality of life, spinal function and stability of internal fixation. Research shows that hypoglycemic drugs can not only control blood glucose level, but also affect the stability of nerve, bone and internal fixation, which is expected to improve the prognosis of spinal surgery in patients with diabetes. Metformin and sitagliptin are widely used hypoglycemic drugs. Studies have shown that metformin can increase bone mineral density in patients and have a protective effect on bones. Sitagliptin induces macrophage polarization of the M2 phenotype and reduces the impaired behavior of osteoblasts on titanium (TI) implants in a dose-dependent manner, thereby enhancing the bone regeneration required for successful orthopedic and dental implants in diabetic patients. However, the effects of these two drugs on the long-term prognosis of diabetic patients after spinal surgery, such as quality of life, spinal function and stability of internal fixation, have not been reported.

This investigation is a prospectie cohort study. The purpose of this study is to determine whether metformin and sitagliptin are associated with patient-reported outcomes and internal fixation stability at one year following elective spine surgery. Providers may use this information to help patients who need elective spinal surgery choose hypoglycemic drugs and to counsel patients with diabetes on expectations following spine surgery.

02

Conditions studied

  • Diabetes Mellitus
  • Spinal Diseases

Browse trials for

Keywords

  • Elective spinal surgery
  • Metformin
  • Sitagliptin
  • Prognosis
03

In context

Spinal Diseases

267 studies on the registry are indexed under Spinal Diseases; 54 are open to participants now.

This study's planned enrollment of 124 is above the median of 108 across 87 observational studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

Xijing Hospital is the lead sponsor of 465 studies on the registry; 157 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A population of diabetic patients requiring elective spinal surgery.

Inclusion criteria

  • Patients undergoing elective spinal surgery;
  • Clinical diagnosis of diabetes (using the diagnostic criteria proposed by the WHO Expert Committee on Diabetes in 1999);
  • Use metformin or sitagliptin;
  • The age ranges from 18 to 90;
  • Sign informed consent.

Exclusion criteria

Exclusion Criteria:

  • Acute traumatic injury;
  • Patients with cerebral hemorrhage, cerebral infarction, Parkinson's disease, spinal cord transverse syndrome, spinal cord hemiere syndrome, Guillan-Barre syndrome and other neurological diseases affecting patients' somatosensory and motor;
  • Combined with rheumatoid arthritis, ankylosing spondylitis and other rheumatoid arthritis;
  • Patients with long-term use of glucocorticoids;
  • complicated with malignant tumor;
  • Pregnant women;
  • Suffering from schizophrenia, bipolar disorder, hysteria and other mental diseases;
  • The use of two or more than two mechanisms of hypoglycemic drugs;
  • Do not sign informed consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
124 participants (estimated)
Patient registry
No

Groups and cohorts

  • Metformin

    Patients who use metformin to control blood sugar level.

    Drug: Hypoglycemic Drugs

  • Sitagliptin

    Patients who use sitagliptin to control blood sugar level.

    Drug: Hypoglycemic Drugs

Interventions

  • DrugHypoglycemic Drugs

    Patients were divided into metformin group and sitagliptin group according to the type of hypoglycemic drugs they took.

06

What researchers measure

Primary outcomes

  1. Preoperative Quality of Life Score

    Preoperative quality of life score will be performed using a Short Form-36 Health Survey (SF-36). SF-36 is a concise health questionnaire. It is widely used to measure the quality of life in the general population, evaluate the efficacy of clinical trials, and evaluate health policy. As a concise health questionnaire, SF-36 comprehensively summarized the quality of life of the respondents from nine aspects: physiological function, physical function, physical pain, general health, energy, social function, emotional function, mental health and health transition.

    Time frame: before surgery

  2. Quality of Life Score at 3 Months after Surgery

    Quality of life score at 3 months after surgery will be performed using a Short Form-36 Health Survey (SF-36). SF-36 is a concise health questionnaire. It is widely used to measure the quality of life in the general population, evaluate the efficacy of clinical trials, and evaluate health policy. As a concise health questionnaire, SF-36 comprehensively summarized the quality of life of the respondents from nine aspects: physiological function, physical function, physical pain, general health, energy, social function, emotional function, mental health and health transition.

    Time frame: at 3 months after surgery

  3. Quality of Life Score at 6 Months after Surgery

    Quality of life score at 6 months after surgery will be performed using a Short Form-36 Health Survey (SF-36). SF-36 is a concise health questionnaire. It is widely used to measure the quality of life in the general population, evaluate the efficacy of clinical trials, and evaluate health policy. As a concise health questionnaire, SF-36 comprehensively summarized the quality of life of the respondents from nine aspects: physiological function, physical function, physical pain, general health, energy, social function, emotional function, mental health and health transition.

    Time frame: at 6 months after surgery

  4. Quality of Life Score at 1 Year after Surgery

    Quality of life score at 1 year after surgery will be performed using a Short Form-36 Health Survey (SF-36). SF-36 is a concise health questionnaire. It is widely used to measure the quality of life in the general population, evaluate the efficacy of clinical trials, and evaluate health policy. As a concise health questionnaire, SF-36 comprehensively summarized the quality of life of the respondents from nine aspects: physiological function, physical function, physical pain, general health, energy, social function, emotional function, mental health and health transition.

    Time frame: at 1 year after surgery.

  5. Preoperative Oswestry Disability Index (ODI) or Neck Disability Index (NDI)

    The ODI and NDI are disease-specific questionnaires designed to gauge disability from the low back (ODI) or neck (NDI) and are scored on a 0-to-100-point scale. Values of \>40 points indicate severe disability.

    Time frame: before surgery

  6. Oswestry Disability Index (ODI) or Neck Disability Index (NDI) at 3 Months after Surgery

    The ODI and NDI are disease-specific questionnaires designed to gauge disability from the low back (ODI) or neck (NDI) and are scored on a 0-to-100-point scale. Values of \>40 points indicate severe disability.

    Time frame: at 3 months after surgery

  7. Oswestry Disability Index (ODI) or Neck Disability Index (NDI) at 6 Months after Surgery

    The ODI and NDI are disease-specific questionnaires designed to gauge disability from the low back (ODI) or neck (NDI) and are scored on a 0-to-100-point scale. Values of \>40 points indicate severe disability.

    Time frame: at 6 months after surgery

  8. Oswestry Disability Index (ODI) or Neck Disability Index (NDI) at 1 Year after Surgery

    The ODI and NDI are disease-specific questionnaires designed to gauge disability from the low back (ODI) or neck (NDI) and are scored on a 0-to-100-point scale. Values of \>40 points indicate severe disability.

    Time frame: at 1 year after surgery

  9. Preoperative Visual Analogue Scale (VAS)

    The VAS is used to assess pain. The basic method is to use a swimming scale about 10cm long, with one side marked with 10 scales, both ends of which are "0" and "10" respectively. 0 indicates no pain, and 10 indicates the most severe pain that is unbearable.

    Time frame: before surgery

  10. Visual Analogue Scale (VAS) at 3 Months after Surgery

    The VAS is used to assess pain. The basic method is to use a swimming scale about 10cm long, with one side marked with 10 scales, both ends of which are "0" and "10" respectively. 0 indicates no pain, and 10 indicates the most severe pain that is unbearable.

    Time frame: at 3 months after surgery

  11. Visual Analogue Scale (VAS) at 6 Months after Surgery

    The VAS is used to assess pain. The basic method is to use a swimming scale about 10cm long, with one side marked with 10 scales, both ends of which are "0" and "10" respectively. 0 indicates no pain, and 10 indicates the most severe pain that is unbearable.

    Time frame: at 6 months after surgery

  12. Visual Analogue Scale (VAS) at 1 Year after Surgery

    The VAS is used to assess pain. The basic method is to use a swimming scale about 10cm long, with one side marked with 10 scales, both ends of which are "0" and "10" respectively. 0 indicates no pain, and 10 indicates the most severe pain that is unbearable.

    Time frame: at 1 year after surgery

Secondary outcomes

  1. Number of Participants with Spinal Fixation Loosening at 3 Months after Surgery

    Spinal fixation loosening is evaluated by anteroposterior and lateral X-ray. The evaluation criteria were: a gap of more than 1mm around the screw is considered as spinal fixation loosening.

    Time frame: at 3 months after surgery

  2. Number of Participants with Spinal Fixation Loosening at 6 Months after Surgery

    Spinal fixation loosening is evaluated by anteroposterior and lateral X-ray. The evaluation criteria were: a gap of more than 1mm around the screw is considered as spinal fixation loosening.

    Time frame: at 6 months after surgery

  3. Number of Participants with Spinal Fixation Loosening at 1 year after Surgery

    Spinal fixation loosening is evaluated by CT scan. The evaluation criteria were: a gap of more than 1mm around the screw is considered as spinal fixation loosening.

    Time frame: at 1 year after surgery

  4. Number of Participants with Spinal Fusion at 3 Months after Surgery

    Dynamic X-ray is used to evaluate the spinal fusion. The criteria of spinal fusion:(1) there is continuous bone trabeculae passing between vertebrae with increased density; (2) The translation on the X-ray dynamic position film is less than 3mm, and the angular motion is less than 5°; (3) The bone connected to the vertebral body is constantly growing; (4) The relative displacement between adjacent spinous processes of fusion segment measured by X-ray dynamic position film is less than or equal to 2 mm.

    Time frame: at 3 months after surgery

  5. Number of Participants with Spinal Fusion at 6 Months after Surgery

    Dynamic X-ray is used to evaluate the spinal fusion. The criteria of spinal fusion:(1) there is continuous bone trabeculae passing between vertebrae with increased density; (2) The translation on the X-ray dynamic position film is less than 3mm, and the angular motion is less than 5°; (3) The bone connected to the vertebral body is constantly growing; (4) The relative displacement between adjacent spinous processes of fusion segment measured by X-ray dynamic position film is less than or equal to 2 mm.

    Time frame: at 6 months after surgery

  6. Number of Participants with Spinal Fusion at 1 Year after Surgery

    Dynamic X-ray is used to evaluate the spinal fusion. The criteria of spinal fusion:(1) there is continuous bone trabeculae passing between vertebrae with increased density; (2) The translation on the X-ray dynamic position film is less than 3mm, and the angular motion is less than 5°; (3) The bone connected to the vertebral body is constantly growing; (4) The relative displacement between adjacent spinous processes of fusion segment measured by X-ray dynamic position film is less than or equal to 2 mm.

    Time frame: at 1 year after surgery

07

Study locations

1 of 1 sites recruiting
  • The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)
    Xi'an, Shaanxi 710032, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05214235
Lead sponsor
Xijing Hospital
Responsible party
FengYafei (Associate professor, Xijing Hospital) — Principal investigator
First posted
Jan 28, 2022
Start date
Feb 7, 2022
Primary completion
Feb 7, 2024 (estimated)
Completion
Feb 29, 2024 (estimated)
Last update
Jun 16, 2022

Study contacts

Yafei Feng, Doctor
Contact
fengyafei2005@163.com
15829552527
Kaili Hao, Master
Contact
haokaili2020@163.com
17683914056

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion